Client News

Novogenia AG Publishes H1 2026 Issuer Report and Advances Strategic Growth Initiatives in Core Business Areas

EU-Funded Q-AID Project Deploys First POLARIS Systems for Quantum-Enhanced MRI Network

AFYREN announces its 2026 half-year financial results

Life Science Intelligence partners with Opus Origin to accelerate the expansion of its premium global platforms for medtech innovation and investment

Galimedix announces participation at fall 2026 investor, partnering, and scientific conferences

Newron presents H1 2026 results and provides corporate update

Formycon sets Benchmark in Biosimilar Development: Scientific Foundation of the innovative Development Program for FYB206 published in the Journal BioDrugs

Abivax Presents Business Updates and First Half 2026 Financial Result

InflaRx to Host Virtual Capital Markets Day

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101